Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04123366
Brief Title: Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)

First Submitted : October 9, 2019
First Submitted that Met QC Criteria : October 9, 2019
First Posted : October 10, 2019

Last Update Submitted that Met QC Criteria : June 23, 2021
Last Update Posted : June 24, 2021 (Estimate)